ERVW-1 and myeloid sarcoma: It has been shown that both HERV-W and HERV-H/F were specifically activated in the circulation and in the central nervous system (CNS) in the majority of MS patients and, particularly, the envelopes (env mRNA and env proteins) appear to be strongly associated with disease activity and progression [6].